100 Clinical Results associated with Motus Biosciences, Inc.
0 Patents (Medical) associated with Motus Biosciences, Inc.
Insmed, a global biopharmaceutical company, completed the acquisition of Motus Biosciences, a developer of tools intended for the development of next-generation gene therapies, for $288m.
100 Deals associated with Motus Biosciences, Inc.
100 Translational Medicine associated with Motus Biosciences, Inc.